Article Text

Download PDFPDF
A new dysferlin gene mutation in a Portuguese family with Miyoshi myopathy
  1. Sandra Ganchinho Lucas1,
  2. Inês Vieira Santos1,
  3. Filipe Jorge Pencas Alfaiate1 and
  4. Ireneia Lino2
  1. 1Medicina 1, Hospital do Espirito Santo EPE, Evora, Portugal
  2. 2Unidade de Hospitalização Domiciliária Polivalente, Hospital do Espírito Santo EPE, Évora, Portugal
  1. Correspondence to Dr Sandra Ganchinho Lucas; slucas{at}


Dysferlinopathies are autosomal recessive muscular dystrophies caused by mutations in the dysferlin gene (DYSF). A 33-year-old man was born to a non-consanguineous couple. At the age of 25 he stared to feel weakness of the distal lower limbs and also experienced episodes of rhabdomyolysis. Electromyography showed a myopathic pattern, and muscle biopsy revealed dystrophic changes with absence of dysferlin. Genetic analysis was positive for a mutation in the c3367_3368del DYSF gene (p.Lys1123GLUFS*2). After 8 years of disease evolution the symptomatology worsened. This is the first report of this mutation of the DYSF gene identified in a non-consanguineous Portuguese family, studied over 8 years. We believe the mutation is responsible for the Miyoshi myopathy. Disease progression cannot be predicted in either the patient or carrier family because there are no similar cases previously described in the literature.

  • genetic screening / counselling
  • muscle disease
  • neuro genetics
  • neuromuscular disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors SLGL is the corresponding author and wrote this case report and researched the data. FJPA and IVS contributed to the interpretation of the results. Literature data was provided by SLGL. IL contributed to the discussion and revision of the critical intellectual content. IL approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.